Fig. 4From: Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studiesBiodistribution studies of [177Lu]Lu-rhPSMA-10.1 (A) and [177Lu]Lu-rhPSMA-10.2 (B) in mice bearing LNCaP tumors at 1, 24 and 168 h p.i. Values are expresses as a percentage of injected dose per gram (%ID/g), mean ± SD (n = 4–5). SI, small intestine; LI, large intestine; SG, salivary glandsBack to article page